Viking Therapeutics’ stock boosted by positive data from trial of treatment for rare metabolic disorder X-ALD
Viking, which is also developing a weight-loss pill, has a buy rating from all 13 analysts offering coverage.
European companies are heading into the upcoming earnings season on shaky ground, but lowered earnings estimates could help them beat...
Ahead of next month’s election, a new Gallup poll has found no overlap at all between Republican and Democratic voters...
‘With the sale of the house, I was able to pay off some small debts, and now I am 100%...
Jefferies estimates that Reddit’s Ebitda will more than double in the next two years to around $450 million.
Hurricane Milton, which is expected to make landfall on Florida’s Gulf coast late Wednesday, has been described as “a dangerous...
Oil futures were lower Wednesday morning ahead of official data on U.S. inventories, extending a sharp pullback seen the previous...
Average Rating